Seeking Alpha

gamarra

gamarra
Send Message
View as an RSS Feed
Latest  |  Highest rated
  • Shares of Amarin (AMRN -4.4%) spike lower after the FDA's latest Orange Book update shows no change in the status of its fish-oil pill Vascepa. M&A speculators had been optimistic on a decision from regulators over the exclusivity of the pill would be coming this month, because last week a draft response letter made the rounds around the FDA which made no mention of 'no decision' this month, as it has previously before. [View news story]
    When is the next Orange Book update is going to be?
    Nov 18 06:39 AM | Likes Like |Link to Comment
COMMENTS STATS
1 Comment
0 Likes